| Company Name: |
Allmpus Laboratories Pvt Ltd
|
| Tel: |
+91-9518738415 +91-9167862134 |
| Email: |
info@allmpus.com |
| Products Intro: |
Product Name:EVEROLIMUS OXEPANE ISOMER
CAS:908340-97-6
Purity:98.62 Package:Customize Packaging (As per customer requirement in Miligram)
|
| Company Name: |
Shanghai Kewel Chemical Co., Ltd.
|
| Tel: |
021-64609169 18901607656 |
| Email: |
greensnown@163.com |
| Products Intro: |
Product Name:Lansoprazole Impurity 77
CAS:908340-97-6
Purity:95+ HPLC; Package:10mg;25mg;50mg;100mg
|
USDOYNAPNXMXOE-SPSCNLKESA-N manufacturers
- Everolimus Isomer C
-
- $0.00 / 5mg
-
2025-03-10
- CAS:908340-97-6
- Min. Order: 5mg
- Purity: 95%+
- Supply Ability: 1000mg
|
| | USDOYNAPNXMXOE-SPSCNLKESA-N Basic information |
| Product Name: | USDOYNAPNXMXOE-SPSCNLKESA-N | | Synonyms: | USDOYNAPNXMXOE-SPSCNLKESA-N;Rapamycin, 9,14-deepoxy-15-deoxo-14-deoxy-9,15-epoxy-15-hydroxy-42-O-(2-hydroxyethyl)-14-oxo- (9CI);Everolimus Isomer C (>60%, contains everolimus);Everolimus Impurity 8 (211-97) (Everolimus EP Impurity C);EVEROLIMUS OXEPANE ISOMER;Lansoprazole Impurity 77 | | CAS: | 908340-97-6 | | MF: | C53H83NO14 | | MW: | 958.24 | | EINECS: | | | Product Categories: | | | Mol File: | 908340-97-6.mol |  |
| | USDOYNAPNXMXOE-SPSCNLKESA-N Chemical Properties |
| Melting point | 61 - 66°C | | Boiling point | 1023.0±65.0 °C(Predicted) | | density | 1.18±0.1 g/cm3(Predicted) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | pka | 9.40±0.70(Predicted) | | color | White to Pale Yellow | | Stability: | Hygroscopic, Revert Back To Everolimus, Unstable in Solution |
| | USDOYNAPNXMXOE-SPSCNLKESA-N Usage And Synthesis |
| Uses | Everolimus Isomer C is an isomer of Everolimus (E945400), a derivative of Rapamycin (R124000). Everolimus inhibits cytokine-mediated lymphocyte proliferation. |
| | USDOYNAPNXMXOE-SPSCNLKESA-N Preparation Products And Raw materials |
|
|
Tag:USDOYNAPNXMXOE-SPSCNLKESA-N(908340-97-6)
Related Product Information
|
|
Everolimus
2-Piperidinecarboxylic acid, 1-[[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrienyl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]oxoacetyl]-, (1S,4R,5E)-1-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-4,6-dimethyl-3,7-dioxo-5-heptenyl es...
42-O-[(1,1-Dimethylethyl)dimethylsilyl]rapamycin
Everolimus EP Impurity E
Everolimus Impurity 1
23,27-Epoxy(7E,15E,17E,19E)-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexam...
Everolimus Related Compound 3
EveroliMus-d4
Everolimus Related Compound 2
Rapamycin, 32-O-demethyl-
Seco Rapamycin
Everolimus Hydrolized Impurity
28-epirapamycin
Everolimus Ring-Opening Impurity
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone
UUVIZQWGMATQNB-STCCUYJISA-N
USMCNVFGYLZLGM-HZQGCWOGSA-N
|